APOE and Alzheimer disease: APOE4 exacerbates tau pathology in both healthy subject‐derived and AD patient‐derived organoids. Cerebral organoids from AD patients are associated with an enhancement of stress granules and disrupted RNA metabolism. Isogenic conversion of APOE4 to APOE3 attenuates the APOE4‐related phenotypes in cerebral organoids from AD patients.